# LENZ Therapeutics, Inc.: Form S-1, filed Sep 11, 2024

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: S-1
- Filed: 2024-09-11
- Accepted by EDGAR: Sep 11, 2024, 20:09 ET
- Period: not reported
- Accession: 0001628280-24-040130
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000162828024040130/lenz-20240911.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000162828024040130/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000162828024040130/lenz-20240911.htm

Filed Sep 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-040130. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.